Among those frequently mutated genes, ASXL1, RUNX1, TP53, and FLT3-ITD mutations have been associated with poor prognosis, whereas NPM1 mutations in the absence of FLT3-ITD have been associated with favorable outcomes in AML [43]. The gene discussed is NPM1; the disease is acute myeloid leukemia.